| Sources | Names Used |
|---|---|
| GDSC1000 | Tivozanib |
| CTRPv2 | tivozanib |
| PharmacoGx | tivozanib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
| Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
| Pubchem: | 9911830 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBA1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | STAT5A | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
| mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-08 |
| mRNA | ERAS | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | HBA2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | RPL7A | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | HBM | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | PABPC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | ALAS2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | TARBP1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
